Di Lu

3PUBLICATIONS
24CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 30, 2026
Direct targeting of LYN kinase by fluphenazine triggers ferroptosis to suppress lung adenocarcinoma.

|Aug 21, 2025
Targeting ATP7A-Dependent Copper Metabolic Homeostasis Induces Cuproptosis and Suppresses the Progression of Mutant KRAS-Driven Lung Cancer.

Jian Zhao, Weijie Zhang, Yuanyuan Zeng

|Mar 22, 2022
First-line PD-1/PD-L1 inhibitors plus chemotherapy versus bevacizumab plus chemotherapy for advanced non-squamous non-small cell lung cancer: A Bayesian network meta-analysis of randomized controlled trials.

Jinzhao Zhai, Jiangyue Lu, Zhibo Zhang

Pageof 1

Frequent Collaborators

2 joint publications

Yuanyuan Zeng

2 joint publications

Zeyi Liu

2 joint publications

Jianjie Zhu

2 joint publications

Jianjun Li